83 FR 38709 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 152 (August 7, 2018)

Page Range		38709-38710
FR Document		2018-16789

Federal Register, Volume 83 Issue 152 (Tuesday, August 7, 2018)

[Federal Register Volume 83, Number 152 (Tuesday, August 7, 2018)]
[Notices]
[Pages 38709-38710]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-16789]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial 
Implementation Cooperative Agreement Applications (U44).
    Date: August 22, 2018.
    Time: 9:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Priti Mehrotra, Ph.D., Chief, Immunology Review 
Branch, Scientific Review Program, Division of Extramural 
Activities, Room #3G40 National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9823, Bethesda, MD 20892-7616, 240-669-5066, 
[email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial

[[Page 38710]]

Planning Grant (R34) and Implementation Cooperative Agreement (U01).
    Date: August 28, 2018.
    Time: 10:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Louis A. Rosenthal, Ph.D., Scientific Review 
Officer Scientific Review Program, Division of Extramural 
Activities, Rm. 3G42B, National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9834, Bethesda, MD 20892-9834, (240) 669-5070, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 1, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-16789 Filed 8-6-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 38709

DEPARTMENT OF HEALTH AND Conference Room 03C227, 251 Bayview Date: September 12, 2018.
HUMAN SERVICES Boulevard, Baltimore, MD. Time: 2:00 p.m. to 4:00 p.m.
Time: October 9, 2018, 11:30 a.m. to 2:30 Agenda: To review and evaluate grant
National Institutes of Health p.m. applications.
Agenda: To review and evaluate personnel Place: National Institute on Aging,
National Institute of Aging; Notice of qualifications and performance, and Gateway Building, Suite 2W–200, 7201
competence of individual investigators. Wisconsin Avenue, Bethesda, MD 20892.
Meeting Place: National Institutes on Aging, Contact Person: Anita H. Undale, Ph.D.,
Pursuant to section 10(d) of the Biomedical Research Center, 3rd Floor MD, Scientific Review Branch, National
Conference Room 03C227, 251 Bayview Institute on Aging, Gateway Building, Suite
Federal Advisory Committee Act, as Boulevard, Baltimore, MD. 2W200, 7201 Wisconsin Avenue, Bethesda,
amended, notice is hereby given of a Time: October 9, 2018, 2:30 p.m. to 5:10 MD 20892, 240–747–7825, anita.undale@
meeting of the Board of Scientific p.m. nih.gov.
Counselors, NIA. Agenda: To review and evaluate personnel (Catalogue of Federal Domestic Assistance
The meeting will be open to the qualifications and performance, and Program Nos. 93.866, Aging Research,
public as indicated below, with competence of individual investigators. National Institutes of Health, HHS)
attendance limited to space available. Place: National Institutes on Aging,
Biomedical Research Center, 3rd Floor Dated: August 1, 2018.
Individuals who plan to attend and Conference Room 03C227, 251 Bayview Melanie J. Pantoja,
need special assistance, such as sign Boulevard, Baltimore, MD. Program Analyst, Office of Federal Advisory
language interpretation or other Time: October 9, 2018, 5:10 p.m. to 6:10 Committee Policy.
reasonable accommodations, should p.m.
Agenda: To review and evaluate personnel [FR Doc. 2018–16786 Filed 8–6–18; 8:45 am]
notify the Contact Person listed below
in advance of the meeting. qualifications and performance, and BILLING CODE 4140–01–P

The meeting will be closed to the competence of individual investigators.
Place: National Institutes on Aging,
public as indicated below in accordance Biomedical Research Center, 3rd Floor DEPARTMENT OF HEALTH AND
with the provisions set forth in section Conference Room 03C227, 251 Bayview HUMAN SERVICES
552b(c)(6), Title 5 U.S.C., as amended Boulevard, Baltimore, MD.
for the review, discussion, and Contact Person: Luigi Ferrucci, Ph.D., MD, National Institutes of Health
evaluation of individual intramural Scientific Director, National Institute on
programs and projects conducted by the Aging, 251 Bayview Boulevard, Suite 100, National Institute of Allergy and
NATIONAL INSTITUTE ON AGING, Room 4C225, Baltimore, MD 21224, 410– Infectious Diseases; Notice of Closed
558–8110, LF27Z@NIH.GOV.
including consideration of personnel Meetings
qualifications and performance, and the (Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research, Pursuant to section 10(d) of the
competence of individual investigators, National Institutes of Health, HHS) Federal Advisory Committee Act, as
the disclosure of which would
Dated: August 1, 2018. amended, notice is hereby given of the
constitute a clearly unwarranted
Melanie J. Pantoja, following meetings.
invasion of personal privacy.
Program Analyst, Office of Federal Advisory The meetings will be closed to the
Name of Committee: Board of Scientific public in accordance with the
Committee Policy.
Counselors, NIA. provisions set forth in sections
Date: October 9, 2018. [FR Doc. 2018–16785 Filed 8–6–18; 8:45 am]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Time: October 9, 2018, 8:00 a.m. to 8:20 BILLING CODE 4140–01–P
as amended. The grant applications and
a.m.
Agenda: To review and evaluate personnel the discussions could disclose
qualifications and performance, and DEPARTMENT OF HEALTH AND confidential trade secrets or commercial
competence of individual investigators. HUMAN SERVICES property such as patentable material,
Place: National Institutes on Aging, and personal information concerning
Biomedical Research Center, 3rd Floor National Institutes of Health individuals associated with the grant
Conference Room 03C227, 251 Bayview applications, the disclosure of which
Boulevard, Baltimore, MD. National Institute on Aging; Notice of would constitute a clearly unwarranted
Time: October 9, 2018, 8:20 a.m. to 10:50 Closed Meeting invasion of personal privacy.
a.m.
Agenda: Committee discussion, individual Pursuant to section 10(d) of the Name of Committee: National Institute of
presentations, laboratory overview. Federal Advisory Committee Act, as Allergy and Infectious Diseases Special
Place: National Institutes on Aging, amended, notice is hereby given of the Emphasis Panel; NIAID SBIR Phase II
Biomedical Research Center, 3rd Floor Clinical Trial Implementation Cooperative
following meeting.
Conference Room 03C227, 251 Bayview Agreement Applications (U44).
The meeting will be closed to the
Boulevard, Baltimore, MD. Date: August 22, 2018.
public in accordance with the Time: 9:00 a.m. to 12:00 p.m.
Time: October 9, 2018, 10:50 a.m. to 11:05
provisions set forth in sections Agenda: To review and evaluate grant
a.m.
Agenda: To review and evaluate personnel 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
qualifications and performance, and as amended. The grant applications and Place: National Institutes of Health, 5601
competence of individual investigators. the discussions could disclose Fishers Lane, Rockville, MD 20892
Place: National Institutes on Aging, confidential trade secrets or commercial (Telephone Conference Call).
Biomedical Research Center, 3rd Floor property such as patentable material, Contact Person: Priti Mehrotra, Ph.D.,
Conference Room 03C227, 251 Bayview and personal information concerning Chief, Immunology Review Branch, Scientific
daltland on DSKBBV9HB2PROD with NOTICES

Boulevard, Baltimore, MD. Review Program, Division of Extramural
individuals associated with the grant
Time: October 9, 2018, 11:05 a.m. to 11:30 Activities, Room #3G40 National Institutes of
applications, the disclosure of which Health/NIAID, 5601 Fishers Lane, MSC 9823,
a.m.
would constitute a clearly unwarranted Bethesda, MD 20892–7616, 240–669–5066,
Agenda: To review and evaluate personnel
qualifications and performance, and invasion of personal privacy. pmehrotra@niaid.nih.gov.
competence of individual investigators. Name of Committee: National Institute on Name of Committee: National Institute of
Place: National Institutes on Aging, Aging Special Emphasis Panel; Metformin Allergy and Infectious Diseases Special
Biomedical Research Center, 3rd Floor and Aging. Emphasis Panel; NIAID Clinical Trial

VerDate Sep<11>2014 16:54 Aug 06, 2018 Jkt 244001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\07AUN1.SGM 07AUN1

38710 Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices

Planning Grant (R34) and Implementation Clinical and Translational R21 and Omnibus Place: National Cancer Institute, Shady
Cooperative Agreement (U01). R03. Grove, 9609 Medical Center Drive, Room
Date: August 28, 2018. Date: September 27, 2018. 7W634, Rockville, MD 20850 (Telephone
Time: 10:00 a.m. to 12:30 p.m. Time: 7:30 a.m. to 5:00 p.m. Conference Call).
Agenda: To review and evaluate grant Agenda: To review and evaluate grant Contact Person: Yasuko Furumoto, Ph.D.,
applications. applications. Scientific Review Officer, Research
Place: National Institutes of Health, 5601 Place: Bethesda North Marriott Hotel & Technology and Contract Review Branch,
Fishers Lane, Rockville, MD 20892 Conference Center, 5701 Marinelli Road, Division of Extramural Activities, National
(Telephone Conference Call). North Bethesda, MD 20852. Cancer Institute, NIH, 9609 Medical Center
Contact Person: Louis A. Rosenthal, Ph.D., Contact Person: Saejeong J. Kim, Ph.D., Drive, Room 7W634, Bethesda, MD 20892–
Scientific Review Officer Scientific Review Scientific Review Officer, Special Review 9750, 240–276–5287, yasuko.furumoto@
Program, Division of Extramural Activities, Branch, Division of Extramural Activities, nih.gov.
Rm. 3G42B, National Institutes of Health/ National Cancer Institute, NIH, 9609 Medical Name of Committee: National Cancer
NIAID, 5601 Fishers Lane, MSC 9834, Center Drive, Room 7W640, Bethesda, MD Institute Special Emphasis Panel; UH2/UH3
Bethesda, MD 20892–9834, (240) 669–5070, 20892–9750, 240–276–5179, saejeong.kim@ Review.
rosenthalla@niaid.nih.gov. nih.gov. Date: November 7, 2018.
(Catalogue of Federal Domestic Assistance Name of Committee: National Cancer Time: 1:00 p.m. to 4:00 p.m.
Program Nos. 93.855, Allergy, Immunology, Institute Initial Review Group, Subcommittee Agenda: To review and evaluate grant
and Transplantation Research; 93.856, J—Career Development. applications.
Microbiology and Infectious Diseases Date: October 11–12, 2018. Place: National Cancer Institute, Shady
Research, National Institutes of Health, HHS) Time: 5:00 p.m. to 4:00 p.m. Grove, 9609 Medical Center Drive, Room
Agenda: To review and evaluate grant 7W110, Rockville, MD 20850 (Telephone
Dated: August 1, 2018.
applications. Conference Call).
Sylvia L. Neal, Place: Bethesda Marriott Suites, 6711 Contact Person: Robert E. Bird, Ph.D.,
Program Analyst, Office of Federal Advisory Democracy Boulevard Bethesda, MD 20817. Scientific Review Officer, Resources and
Committee Policy. Contact Person: Tushar Deb, Ph.D., Training Review Branch, Division of
[FR Doc. 2018–16789 Filed 8–6–18; 8:45 am] Scientific Review Officer, Resources and Extramural Activities, National Cancer
BILLING CODE 4140–01–P
Training Review Branch, Division of Institute, NIH, 9609 Medical Center Drive,
Extramural Activities, National Cancer Room 7W110, Bethesda, MD 20892–9750,
Institute, NIH, 9609 Medical Center Drive, 240–276–6344, birdr@mail.nih.gov.
Room 7W624, Bethesda, MD 20892–9750, (Catalogue of Federal Domestic Assistance
DEPARTMENT OF HEALTH AND 240–276–6132, tushar.deb@nih.gov.
HUMAN SERVICES Program Nos. 93.392, Cancer Construction;
Name of Committee: National Cancer 93.393, Cancer Cause and Prevention
National Institutes of Health Institute Special Emphasis Panel; Innovative Research; 93.394, Cancer Detection and
Molecular and Cellular Analysis Diagnosis Research; 93.395, Cancer
National Cancer Institute; Notice of Technologies (IMAT). Treatment Research; 93.396, Cancer Biology
Date: October 19, 2018. Research; 93.397, Cancer Centers Support;
Closed Meetings Time: 8:30 a.m. to 5:30 p.m. 93.398, Cancer Research Manpower; 93.399,
Pursuant to section 10(d) of the Agenda: To review and evaluate grant Cancer Control, National Institutes of Health,
Federal Advisory Committee Act, as applications. HHS)
Place: National Cancer Institute, Shady
amended, notice is hereby given of the Dated: August 1, 2018.
Grove, 9609 Medical Center Drive, Room
following meetings. 2E908, Rockville, MD 20850. Melanie J. Pantoja,
The meetings will be closed to the Contact Person: Yasuko Furumoto, Ph.D., Program Analyst, Office of Federal Advisory
public in accordance with the Scientific Review Officer, Research Committee Policy.
provisions set forth in sections Technology and Contract Review Branch, [FR Doc. 2018–16784 Filed 8–6–18; 8:45 am]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Division of Extramural Activities, National
BILLING CODE 4140–01–P
as amended. The grant applications and Cancer Institute, NIH, 9609 Medical Center
the discussions could disclose Drive, Room 7W634, Bethesda, MD 20892–
confidential trade secrets or commercial 9750, 240–276–5287, yasuko.furumoto@
nih.gov. DEPARTMENT OF HEALTH AND
property such as patentable material, HUMAN SERVICES
and personal information concerning Name of Committee: National Cancer
individuals associated with grant Institute Special Emphasis Panel; R25
Review. National Institutes of Health
applications, the disclosure of which Date: October 24, 2018.
would constitute a clearly unwarranted Time: 1:00 p.m. to 5:00 p.m. Government-Owned Inventions;
invasion of personal privacy. Agenda: To review and evaluate grant Availability for Licensing
Name of Committee: National Cancer applications. AGENCY: National Institutes of Health,
Institute Special Emphasis Panel; NCI Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
HHS.
Clinical and Translational Exploratory/
Developmental Studies. 7W110, Rockville, MD 20850 (Telephone ACTION: Notice.
Date: September 14, 2018. Conference Call).
Contact Person: Robert E. Bird, Ph.D., SUMMARY: The inventions listed below
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant Scientific Review Officer, Resources and are owned by an agency of the U.S.
applications. Training Review Branch, Division of Government and are available for
Place: The Westin Arlington Gateway, 801 Extramural Activities, National Cancer licensing in the U.S.
North Glebe Road, Arlington, VA 22203. Institute, NIH, 9609 Medical Center Drive, FOR FURTHER INFORMATION CONTACT:
Contact Person: Robert S. Coyne, Ph.D., Room 7W110, Bethesda, MD 20892–9750, Licensing information may be obtained
daltland on DSKBBV9HB2PROD with NOTICES

Scientific Review Officer, Special Review 240–276–6344, birdr@mail.nih.gov.
by emailing the indicated licensing
Branch, Division of Extramural Activities, Name of Committee: National Cancer
National Cancer Institute, NIH, 9609 Medical
contact at the National Heart, Lung, and
Institute Special Emphasis Panel; Innovative
Center Drive, Room 7W236, Bethesda, MD Molecular Analysis Technologies (IMAT).
Blood, Office of Technology Transfer
20892–9750, 240–276–7684, coyners@ Date: November 1, 2018. and Development Office of Technology
mail.nih.gov. Time: 11:00 a.m. to 2:00 p.m. Transfer, 31 Center Drive, Room 4A29,
Name of Committee: National Cancer Agenda: To review and evaluate grant MSC2479, Bethesda, MD 20892–2479;
Institute Special Emphasis Panel; SEP–7: NCI applications. telephone: 301–402–5579. A signed

VerDate Sep<11>2014 16:54 Aug 06, 2018 Jkt 244001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\07AUN1.SGM 07AUN1

Document Created: 2018-11-06 10:38:49
Document Modified: 2018-11-06 10:38:49

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		August 22, 2018.
FR Citation		83 FR 38709

83 FR 38709 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 152 (August 7, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health